Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study

The Lancet

Volumn 392, Issue 10146, 2018, Pages 477-486

  Rawshani, Araz ^a   Sattar, Naveed ^b   Franzén, Stefan ^c   Rawshani, Aidin ^d   Hattersley, Andrew T ^e   Svensson, Ann Marie ^c   Eliasson, Björn ^a   Gudbjörnsdottir, Soffia ^b,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c National Diabetes Register   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; ATRIAL FIBRILLATION; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART FAILURE; HEART PROTECTION; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; MORTALITY RISK; ONSET AGE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SURVIVAL; YOUNG ADULT; ADOLESCENT; AGE; CHILD; DIABETIC COMPLICATION; INFANT; NEWBORN; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; REGISTER; SWEDEN;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SWEDEN; YOUNG ADULT;

EID: 85051120399     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(18)31506-X     Document Type: Article

References (38)

1. Gale, EAM, The rise of childhood type 1 diabetes in the 20th century. Diabetes 51 (2002), 3353–3361.
2. Rawshani, A, Rawshani, A, Franzén, S, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med 376 (2017), 1407–1418.
3. Lind, M, Svensson, A-M, Kosiborod, M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 371 (2014), 1972–1982.
4. Livingstone, SJ, Levin, D, Looker, HC, et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008–2010. JAMA 313 (2015), 37–44.
5. de Ferranti, SD, de Boer, IH, Fonseca, V, et al. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care 37 (2014), 2843–2863.
6. Rawshani, A, Rawshani, A, Franzén, S, et al. Range of risk factor levels: control, mortality, and cardiovascular outcomes in type 1 diabetes mellitus. Circulation 135 (2017), 1522–1531.
7. Ahlqvist, E, Storm, P, Käräjämäki, A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 6 (2018), 361–369.
8. Steinarsson, AO, Rawshani, A, Gudbjörnsdottir, S, Franzén, S, Svensson, A-M, Sattar, N, Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register. Diabetologia 61 (2018), 599–606.
9. Huo, L, Magliano, DJ, Rancière, F, et al. Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997–2011. Diabetologia 61 (2018), 1055–1063.
10. Dahlquist, G, Källén, B, Mortality in childhood-onset type 1 diabetes: a population-based study. Diabetes Care 28 (2005), 2384–2387.
11. Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Mortality in type 1 diabetes in the DCCT/EDIC versus the general population. Diabetes Care 39 (2016), 1378–1383.
12. Morgan, E, Black, CR, Abid, N, Cardwell, CR, McCance, DR, Patterson, CC, Mortality in type 1 diabetes diagnosed in childhood in Northern Ireland during 1989–2012: a population-based cohort study. Pediatr Diabetes 19 (2018), 166–170.
13. Harjutsalo, V, Maric-Bilkan, C, Forsblom, C, Groop, P-H, Impact of sex and age at onset of diabetes on mortality from ischemic heart disease in patients with type 1 diabetes. Diabetes Care 37 (2014), 144–148.
14. Conway, BN, Lopes-Virella, MF, Blot, WJ, Late adulthood mortality among African-American and white American people with Type 1 diabetes according to age at diabetes diagnosis. Diabetic Med, 142, 2018, 612.
15. Tancredi, M, Rosengren, A, Svensson, A-M, et al. Excess mortality among persons with type 2 diabetes. N Engl J Med 373 (2015), 1720–1732.
16. Eeg-Olofsson, K, Cederholm, J, Nilsson, PM, et al. Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care 33 (2010), 1640–1646.
17. Rawshani, A, Landin-Olsson, M, Svensson, A-M, et al. The incidence of diabetes among 0–34 year olds in Sweden: new data and better methods. Diabetologia 57 (2014), 1375–1381.
18. Lind, M, Bounias, I, Olsson, M, Gudbjörnsdottir, S, Svensson, A-M, Rosengren, A, Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet 378 (2011), 140–146.
19. Ludvigsson, JF, Andersson, E, Ekbom, A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health, 11, 2011, 450.
20. Nordestgaard, BG, Chapman, MJ, Humphries, SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 34 (2013), 3478–3490.
21. Prospective Studies Collaboration and Asia Pacific Cohort Studies Collaboration. Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies. Lancet Diabetes Endocrinol 6 (2018), 538–546.
22. Ference, BA, Ginsberg, HN, Graham, I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 38 (2017), 2459–2472.
23. Paneni, F, Beckman, JA, Creager, MA, Cosentino, F, Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J 34 (2013), 2436–2443.
24. Leete, P, Willcox, A, Krogvold, L, et al. Differential insulitic profiles determine the extent of β-cell destruction and the age at onset of type 1 diabetes. Diabetes 65 (2016), 1362–1369.
25. Arif, S, Leete, P, Nguyen, V, et al. Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes. Diabetes 63 (2014), 3835–3845.
26. Singh, TP, Groehn, H, Kazmers, A, Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol 41 (2003), 661–665.
27. Järvisalo, MJ, Raitakari, M, Toikka, JO, et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 109 (2004), 1750–1755.
28. Costacou, T, Lopes-Virella, MF, Zgibor, JC, et al. Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. J Diabetes Complicat 19 (2005), 183–193.
29. Vinik, AI, Ziegler, D, Diabetic cardiovascular autonomic neuropathy. Circulation 115 (2007), 387–397.
30. Margeirsdottir, HD, Stensaeth, KH, Larsen, JR, Brunborg, C, Dahl-Jørgensen, K, Early signs of atherosclerosis in diabetic children on intensive insulin treatment: a population-based study. Diabetes Care 33 (2010), 2043–2048.
31. Cholesterol Treatment Trialists' (CTT) Collaborators, Kearney, PM, Blackwell, L, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 371 (2008), 117–125.
32. Haller, MJ, Stein, JM, Shuster, JJ, et al. Pediatric Atorvastatin in Diabetes Trial (PADIT): a pilot study to determine the effect of atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 22 (2009), 65–68.
33. de Ferranti, SD, de Boer, IH, Fonseca, V, et al. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation 130 (2014), 1110–1130.
34. Hero, C, Rawshani, A, Svensson, A-M, et al. Association between use of lipid-lowering therapy and cardiovascular diseases and death in individuals with type 1 diabetes. Diabetes Care 39 (2016), 996–1003.
35. Marcovecchio, ML, Chiesa, ST, Bond, S, et al. ace inhibitors and statins in adolescents with type 1 diabetes. N Engl J Med 377 (2017), 1733–1745.
36. Livingstone, SJ, Looker, HC, Hothersall, EJ, et al. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med, 9, 2012, e1001321.
37. JBS3 Board. Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart 100:suppl 2 (2014), ii1–i67.
38. Ford, I, Murray, H, Packard, CJ, et al. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med 357 (2007), 1477–1486.